⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2025Annals of Internal Medicine

Cytisinicline for 6 or 12 wk increased smoking cessation rates after treatment and up to 24 wk

View at Publisher

Ask AI

Bookmark

Share

Key Points

Cytisinicline significantly increased smoking cessation rates after treatment, and the benefits lasted for up to 24 weeks.
The treatment led to a notable increase in cessation rates, with a focus on 6 or 12-week durations.
Observational analysis shows that cytisinicline significantly impacts public health by improving smoking cessation outcomes.
These findings point to potential long-term benefits of cytisinicline for individuals seeking to quit smoking.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis found higher smoking cessation rates with cytisinicline treatment in adults, suggesting effectiveness for public health.

Abstract

GIM/FP/GP: [Formula: see text] Public Health: [Formula: see text].

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

David King (2025) studied this question.

synapsesocial.com/papers/68bb4d206d6d5674bcd00f23 https://doi.org/10.7326/annals-25-02977-jc

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cytisinicline for smoking cessation among patients with a history of cancer: A post-hoc analysis from two phase 3 clinical trials.Human Clinical Trial · 2026
2An evaluation of cytisinicline for smoking cessation in adult smokersHuman Clinical Trial · 2026 · 1 citations
3Cytisine for smoking cessation: A systematic review and meta-analysis suggesting potential benefits of extended treatment protocols2025
4Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial)Cohort Study · 2025
5D102-18 Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-adjusted Indirect Comparison (MAIC)RCT · 2026

Comparative Effectiveness of Cytisinicline and Varenicline for Smoking Cessation: A Matching-Adjusted Indirect Comparison (MAIC)2026
Cytisine versus Nicotine for Smoking Cessation2014
Cytisinicline More Than Doubled Chances of Quitting E-Cigarettes2024
Impact of Unrestricted Artificial Intelligence Scribe Deployment in a Single Health System on Clinician Workload and ProductivityAnnals of Internal Medicine · 2026
The Hidden Human Costs of Ambient ScribesAnnals of Internal Medicine · 2026

More from Annals of Internal Medicine

More from The University of Queensland